The recent advancement of TCR-T cell therapies for cancer treatment
Acta Biochimica et Biophysica Sinica · 2024
DOI: 10.3724/abbs.2024034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2024. Verfasst von Xiang Zhao und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Antigen, T-Cell, Immunotherapy, Adoptive, Antigens, Neoplasm. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Adoptive cell therapies involve infusing engineered immune cells into cancer patients to recognize and eliminate tumor cells. Adoptive cell therapy, as a form of living drug, has undergone explosive growth over the past decade. The recognition of tumor antigens by the T-cell receptor (TCR) is one of the natural mechanisms that the immune system used to eliminate tumor cells. TCR-T cell therapy, which involves introducing exogenous TCRs into patients' T cells, is a novel cell therapy strategy. TCR-T cell therapy can target the entire proteome of cancer cells. Engineering T cells with exogenous TCRs to help patients combat cancer has achieved success in clinical trials, particularly in treating solid tumors. In this review, we examine the progress of TCR-T cell therapy over the past five years. This includes the discovery of new tumor antigens, protein engineering techniques for TCR, reprogramming strategies for TCR-T cell therapy, clinical studies on TCR-T cell therapy, and the advancement of TCR-T cell therapy in China. We also propose several potential directions for the future development of TCR-T cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Zhao, X., Shao, S., & Hu, L. (2024). The recent advancement of TCR-T cell therapies for cancer treatment. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024034
Vancouver
Zhao X, Shao S, Hu L. The recent advancement of TCR-T cell therapies for cancer treatment. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2024034
BibTeX
@article{Zhao2024,
author = {Zhao, Xiang and Shao, Shuai and Hu, Lanxin},
title = {The recent advancement of TCR-T cell therapies for cancer treatment},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2024},
doi = {10.3724/abbs.2024034}
}
EUVIMED